Back to Search Start Over

THU0577 Do raynaud phenomenon negative juvenile systemic scleroderma patients have a different pattern of organ involvement as raynaud phenomenon positive patients?

Authors :
M. Katsikas
T. Avcin
J. Anton
Tilmann Kallinich
I. Foeldvari
W.A. Sifuentes-Giraldo
R. Cimaz
M. T. Terreri
K. Minden
N. Helmus
Sabrina Mai Nielsen
Mahesh Janarthanan
Liora Harel
Clarissa Pilkington
Simone Appenzeller
Lillemor Berntson
Thomas J. A. Lehman
Ekaterina Alexeeva
Kathryn S. Torok
P. Costa Reis
Flavio Sztajnbok
Vanessa Smith
J. Brunner
Despina Eleftheriou
Jens Klotsche
M. Moll
MJ Santos
Anne M. Stevens
Cristina Battagliotti
Amra Adrovic
Dana Nemcova
Ozgur Kasapcopur
Valda Stanevicha
M. Kostic
Yosef Uziel
Source :
THURSDAY, 14 JUNE 2018.
Publication Year :
2018
Publisher :
BMJ Publishing Group Ltd and European League Against Rheumatism, 2018.

Abstract

Background Juvenile systemic scleroderma (jSSc) is an orphan disease, with an estimated prevalence of 3 per 1000 000 children. Most jSSc patients primarily present with Raynaud phenomenon (RP). We investigated in our patient of the juvenile scleroderma inception cohort, how fare patients with (RP+) and without (RP-) RP differed in their clinical presentation at enrolment. Methods The jSSc is a prospective cohort of jSSc patients. Patients were enrolled who were diagnosed with jSSc, had a jSSc onset age under 16 years and were younger as age of 18 years at the time of inclusion. The patients are prospectively assessed every 6 months according to a standardised protocol. We reviewed the organ involvement pattern of our patients currently followed in the cohort. Results 100 patients are currently followed in the cohort and 89 (89%) of them had RP. The female/male ratio was lower in the RP +group, 3.7:1 compared to 4.5:1(p=0.808). Diffuse subtype was more common in the RP +group, 72% compared to 63%. Mean age of onset of first non- Raynaud symptomatic was 10.4 years in both groups. Mean disease duration was slightly higher in the RP +group, 3.4 compared to 2.2 years. ANA positivity was higher in the RP +group, 88% compared to 70% (p=0.48). Anti-Scl70 was 34% in the RP +and 20% in the RP-group (p=0.34). Interestingly 7% of RP +but none of the RP +were anti-centromere positive. The mean modified skin score was lower in RP +group (mean of 14.8 compared to 17.0). There were significantly more nailfold capillary changes (70% compared to 18%, p=0.001) and a higher rate of history of ulceration in the RP +group (49% compared to 20%, p=0.083). Decreased DLCO and FVC Conclusions The RP– group differed from RP +group in the clinical presentation at enrolment. The absence of Raynaud phenomenon was associated with a decreased rate of history of ulceration, no occurrence of pulmonary hypertension. Interestingly higher rate of urinary sedimentary changes and no anticentromere positivity was observed in RP- patients. Disclosure of Interest None declared

Details

Database :
OpenAIRE
Journal :
THURSDAY, 14 JUNE 2018
Accession number :
edsair.doi...........9752a866324378de4215e0a62eab3e71
Full Text :
https://doi.org/10.1136/annrheumdis-2018-eular.2913